Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of
cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid …

Tumor metabolism supports the energetic and biosynthetic needs of rapidly proliferating
cancer cells and modifies intra-and intercellular signaling to enhance cancer cell invasion …

Tumour metabolism is controlled by coordinated changes in metabolite abundance and
gene expression, but simultaneous quantification of metabolites and transcripts in primary …

African-American (AA) men are more likely to be diagnosed with and die from prostate
cancer than European American (EA) men. Despite the central role of the androgen receptor …

Metabolomics combined with machine learning methods (MLMs), is a powerful tool for
searching novel diagnostic panels. This study was intended to use targeted plasma …

Simple Summary Early diagnosis of renal cell carcinoma (RCC) is challenging and typically
incidental. Currently, several therapeutic strategies are used for the treatment; however, no …

Despite the adoption of novel therapeutical approaches, the outcomes for glioblastoma
(GBM) patients remain poor. In the present study, we investigated the prognostic impact of …

Simple Summary Correct identification of subjects at high risk is critical in the prevention and
early screening of prostate cancer (PCa). Analysis of metabolites in biofluids has shown to …

We collected surface-enhanced Raman spectroscopy (SERS) data from the serum of 729
patients with prostate cancer or benign prostatic hyperplasia (BPH), corresponding to their …

Prostate cancer (PCa) is today the second most common cancer in the world, with almost
400,000 deaths annually. Multiple factors are involved in the etiology of PCa, such as older …